The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
relapsing-remitting Multiple Sclerosis (MS),
at least 2 relapses in previous 2 years prior to copaxone or interferon beta treatment,
ambulant patients i.e disability score EDSS MAX 5,5,
clinically stable MS
relapse free and steroid free at least 30 days prior to start copaxone treatment
hypersensitivity to glatiramer acetate or mannitol,
fertile female not willing to use effective contraception,
previous treatment with copaxone
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.